NCT04115306
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04115306
Title Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer (Dauntless-1)
Acronym Dauntless-1
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Phoenix Molecular Designs
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Duarte California 91010 United States Details
City of Hope Orange County, Lennar Irvine California 92618 United States Details
University of California, Los Angeles (UCLA) Los Angeles California 90095 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
City of Hope Chicago Zion Illinois 60099 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Profound Research Farmington Hills Michigan 48334 United States Details
Ohio State University Columbus Ohio 43210 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field